Catalyst Wire Dossier Catalyst Wire Dossier

Birch Pollen Allergoid Immunotherapy (Aluminium hydroxide-adsorbed)

birch pollen allergoid immunotherapy · Allergopharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Birch Pollen Allergoid Immunotherapy (Aluminium hydroxide-adsorbed), covering 2014-07-03 to 2014-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens [Phase 3]

See pricing